Kaiser Permanente Ventures

Kaiser Permanente Ventures is the corporate venture arm of Kaiser Permanente, the integrated health system and insurer, investing in digital health, medical devices, healthcare IT, and selectively life sciences companies that align with Kaiser’s strategic priorities. The fund deploys balance sheet capital with checks generally in the $3M to $15M range at Series B and C, often as a strategic co-investor alongside financial leads, with the explicit goal of building partnership and pilot pipeline for Kaiser’s integrated delivery system. Healthcare exposure is total. AI focus is meaningful where AI improves clinical workflow, population health, or member engagement at scale. Founders best suited are post-product Series B and C CEOs with proven commercial traction at health systems or payers, who can manage the complexity of a large integrated delivery system as both an investor and potential customer, and who would benefit from access to Kaiser’s clinical infrastructure for pilots and validation studies. Founders who do not fit include consumer wellness without a clinical angle, therapeutics, pre-product seed teams, and digital health teams unwilling to engage in long enterprise sales cycles. Geographic preference is US with a California bias given Kaiser’s footprint. The entry path is warm introduction through a Kaiser executive, a Kaiser Permanente Innovation contact, a portfolio CEO, or a healthcare investment banker. LinkedIn outreach to a Kaiser Permanente Ventures investor with a clear strategic articulation is a reasonable secondary option. Expect long diligence cycles, structured partnership conversations, and a strategic partner that moves at the pace of an integrated delivery system.